scholarly article | Q13442814 |
P2093 | author name string | Hong Ji | |
Jian Ge | |||
Yingying Zhang | |||
Yu Jia | |||
Yiqing Li | |||
Yehong Zhuo | |||
Yingting Zhu | |||
P2860 | cites work | The number of people with glaucoma worldwide in 2010 and 2020 | Q24679554 |
Pathobiology of wound healing after glaucoma filtration surgery | Q28073856 | ||
Rapamycin (sirolimus) inhibits proliferating cell nuclear antigen expression and blocks cell cycle in the G1 phase in human keratinocyte stem cells | Q28378927 | ||
Synergistic Effect of Artificial Tears Containing Epigallocatechin Gallate and Hyaluronic Acid for the Treatment of Rabbits with Dry Eye Syndrome | Q28552083 | ||
Biologic basis for interleukin-1 in disease | Q29619853 | ||
Mechanisms of fibrosis: therapeutic translation for fibrotic disease | Q29620307 | ||
Preoperative nonsteroidal anti-inflammatory drug or steroid and outcomes after trabeculectomy: a randomized controlled trial | Q33551981 | ||
Evaluation of pirfenidone as a new postoperative antiscarring agent in experimental glaucoma surgery | Q33823508 | ||
HLA-DR expression as a biomarker of inflammation for multicenter clinical trials of ocular surface disease | Q33861286 | ||
Wound healing modulation after glaucoma surgery | Q33940063 | ||
Research on the stability of a rabbit dry eye model induced by topical application of the preservative benzalkonium chloride | Q34206447 | ||
Ocular Surface and External Filtration Surgery: Mutual Relationships. | Q50701314 | ||
Interleukin-6 and tumor necrosis factor-alpha levels in tears of patients with dry eye syndrome. | Q53572321 | ||
Evaluation of Chitosan/Aptamer Targeting TGF-β Receptor II Thermo-Sensitive Gel for Scarring in Rat Glaucoma Filtration Surgery. | Q55048935 | ||
Impression cytology | Q68129996 | ||
Combined non-steroidal therapy in experimental corneal injury | Q73485091 | ||
Effect of varying the mitomycin-C treatment area in glaucoma filtration surgery in the rabbit | Q73512817 | ||
Denervation of rabbit lacrimal gland increases levels of transferrin and unidentified tear proteins of 44 and 36 kDa | Q78094377 | ||
Prevalence of signs and symptoms of ocular surface disease in individuals treated and not treated with glaucoma medication | Q83582557 | ||
Establishment of a rabbit model for keratoconjunctivitis sicca | Q84323936 | ||
Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension | Q84448763 | ||
Epithelial mucins of the ocular surface: structure, biosynthesis and function | Q34344827 | ||
Non-Smad TGF-beta signals | Q34443708 | ||
The core mechanism of dry eye disease is inflammation | Q34510429 | ||
Endocytosis and intracellular trafficking of ErbBs | Q34827744 | ||
Establishment of the mild, moderate and severe dry eye models using three methods in rabbits | Q35008077 | ||
Grading Of Corneal and Conjunctival Staining in the Context of Other Dry Eye Tests | Q35542950 | ||
Trefoil factor family 1, MUC5AC and human leucocyte antigen-DR expression by conjunctival cells in patients with glaucoma treated with chronic drugs: could these markers predict the success of glaucoma surgery? | Q35762703 | ||
Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis | Q36028616 | ||
Dry Eye Signs and Symptoms Persist During Systemic Neutralization of IL-1β by Canakinumab or IL-17A by Secukinumab | Q36250852 | ||
Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro | Q36288420 | ||
Tear cytokine profiles in dysfunctional tear syndrome. | Q36637791 | ||
Inflammatory Response to Lipopolysaccharide on the Ocular Surface in a Murine Dry Eye Model. | Q36872927 | ||
TGF-beta, Smad3 and the process of progressive fibrosis. | Q36883832 | ||
Dry eye disease: an immune-mediated ocular surface disorder | Q36916372 | ||
Non-Smad signaling pathways | Q37893980 | ||
Animal models to assess the therapeutic efficacy of human serum and serum-converted platelet lysates for dry eye syndrome: Seeing is believing | Q38533731 | ||
Conjunctival fibrosis following filtering glaucoma surgery | Q38671309 | ||
Dry Eye Disease: Present Challenges in the Management and Future Trends | Q38853787 | ||
Transforming growth factor-β1 induces fibrosis in rat meningeal mesothelial cells via the p38 signaling pathway | Q39675620 | ||
Wound healing in glaucoma filtering surgery | Q39697792 | ||
Effects of Gelatin Hydrogel Containing Anti-Transforming Growth Factor-β Antibody in a Canine Filtration Surgery Model. | Q41991130 | ||
A rabbit dry eye model induced by topical medication of a preservative benzalkonium chloride | Q42435289 | ||
Role of Th17 cells in the immunopathogenesis of dry eye disease | Q42694095 | ||
Histopathologic study of the Molteno glaucoma implant in three patients. | Q43412818 | ||
Signs and symptoms of ocular surface disease in patients on topical intraocular pressure-lowering therapy | Q43983684 | ||
Control of wound healing after glaucoma surgery. Effect and inhibition of the growth factor TGF-beta | Q44130214 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P577 | publication date | 2017-05-28 | |
P1433 | published in | International Journal of Molecular Sciences | Q3153277 |
P1476 | title | The Effect of Dry Eye Disease on Scar Formation in Rabbit Glaucoma Filtration Surgery | |
P478 | volume | 18 |
Q89910553 | Mitochondrial Dysfunctions May Be One of the Major Causative Factors Underlying Detrimental Effects of Benzalkonium Chloride | cites work | P2860 |
Search more.